These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1903199)
1. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Winnie GB; Cowan RG Pediatr Pulmonol; 1991; 10(2):92-100. PubMed ID: 1903199 [TBL] [Abstract][Full Text] [Related]
2. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis. Cowan RG; Winnie GB J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. Kerem E; Corey M; Gold R; Levison H J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790 [TBL] [Abstract][Full Text] [Related]
4. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842 [TBL] [Abstract][Full Text] [Related]
6. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis. Elborn JS; Cordon SM; Shale DJ Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287 [TBL] [Abstract][Full Text] [Related]
7. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pamukcu A; Bush A; Buchdahl R Pediatr Pulmonol; 1995 Jan; 19(1):10-5. PubMed ID: 7675552 [TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis. Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928 [TBL] [Abstract][Full Text] [Related]
9. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889 [TBL] [Abstract][Full Text] [Related]
10. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418 [TBL] [Abstract][Full Text] [Related]
11. Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis. Dasgupta MK; Zuberbuhler P; Abbi A; Harley FL; Brown NE; Lam K; Dossetor JB; Costerton JW J Clin Immunol; 1987 Jan; 7(1):51-8. PubMed ID: 3104391 [TBL] [Abstract][Full Text] [Related]
12. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications]. Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization. Aebi C; Theiler F; Aebischer CC; Schoeni MH Pediatr Infect Dis J; 2000 Mar; 19(3):207-12. PubMed ID: 10749460 [TBL] [Abstract][Full Text] [Related]
15. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. Hancock RE; Mouat EC; Speert DP J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943 [TBL] [Abstract][Full Text] [Related]
16. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre. da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217 [TBL] [Abstract][Full Text] [Related]
17. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa. Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094 [TBL] [Abstract][Full Text] [Related]
18. Gastric acid inhibition for fat malabsorption or gastroesophageal reflux disease in cystic fibrosis: longitudinal effect on bacterial colonization and pulmonary function. van der Doef HP; Arets HG; Froeling SP; Westers P; Houwen RH J Pediatr; 2009 Nov; 155(5):629-33. PubMed ID: 19683256 [TBL] [Abstract][Full Text] [Related]
19. [Association between chronic colonization or infection with Pseudomonas aeruginosa and bronchial hyperreactivity in patients with cystic fibrosis]. Valverde-Molina J; Sánchez-Solís M; Pastor-Vivero MD; García-Marcos L Arch Bronconeumol; 2008 Apr; 44(4):180-4. PubMed ID: 18423178 [TBL] [Abstract][Full Text] [Related]
20. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection. Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]